Oncogenic JAK2V617Fcauses PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

A Prestipino, AJ Emhardt, K Aumann, D O'Sullivan, SP Gorantla, S Duquesne, W Melchinger, L Braun, S Vuckovic, M Boerries, H Busch, S Halbach, S Pennisi, T Poggio, P Apostolova, P Veratti, M Hettich, G Niedermann, M Bartholomä, K ShoumariyehJS Jutzi, J Wehrle, C Dierks, H Becker, A Schmitt-Graeff, M Follo, D Pfeifer, J Rohr, S Fuchs, S Ehl, FA Hartl, S Minguet, C Miething, FH Heidel, N Kröger, I Triviai, T Brummer, J Finke, AL Illert, E Ruggiero, C Bonini, J Duyster, HL Pahl, SW Lane, GR Hill, BR Blazar, N Von Bubnoff, EL Pearce, R Zeiser

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Oncogenic JAK2<sup>V617F</sup>causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms'. Together they form a unique fingerprint.

Medicine & Life Sciences